(Q44410457)

2 December 2017

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease (English)

1 reference

dementia with Lewy bodies

2 December 2017

0 references

0 references

1 reference

1 reference

3

1 reference

2 December 2017

Margaret A Piggott

1

1 reference

2 December 2017

Jonathan Owens

2

1 reference

2 December 2017

Sean Colloby

4

1 reference

2 December 2017

John Fenwick

5

1 reference

2 December 2017

David Wyper

6

1 reference

2 December 2017

Evelyn Jaros

7

1 reference

2 December 2017

Mary Johnson

8

1 reference

2 December 2017

Robert H Perry

9

1 reference

2 December 2017

Elaine K Perry

10

1 reference

2 December 2017

1 March 2003

1 reference

Journal of Chemical Neuroanatomy

2 December 2017

1 reference

2 December 2017

25

1 reference

2 December 2017

3

1 reference

2 December 2017

161-173

1 reference

Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Serotonergic innervation of the primate claustrum

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Subcellular redistribution of m2 muscarinic acetylcholine receptors in striatal interneurons in vivo after acute cholinergic stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Neuroreceptor changes in the putamen of alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. III. Results in Parkinson's disease cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Using single photon emission tomography (SPECT) and positron emission tomography (PET) to trace the distribution of muscarinic acetylcholine receptor (MACHR) binding radioligands

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

A novel muscarinic M(4) receptor antagonist provides further evidence of an autoreceptor role for the muscarinic M(2) receptor sub-type

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Regional Alterations in M., Muscarinic Receptor-G Protein Coupling in Alzheimerʼs Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors m1-m4

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Synaptic organization of claustral and geniculate afferents to the visual cortex of the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

The topographic distribution of brain atrophy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Some cholinergic themes related to Alzheimer's disease: synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

The pedunculopontine nucleus and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Clinical neurochemistry: developments in dementia research based on brain bank material

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Brain processing of visual sexual stimuli in human males.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cholinergic activity and amyloid precursor protein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Cholinergic markers in degenerative parkinsonism: autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Muscarinic receptor subtypes involved in hippocampal circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Alterations of muscarinic acetylcholine receptor subtypes in diffuse lewy body disease: relation to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

In vivo autoradiography of radioiodinated (R)-3-quinuclidinyl (S)-4-iodobenzilate [(R, S)-IQNB] and (R)-3-quinuclidinyl (R)-4-iodobenzilate [(R,R)-IQNB]. Comparison of the radiolabelled products of a novel tributylstannyl precursor with those of the

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Postmortem changes in binding to the muscarinic receptor from human cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Quantitative autoradiography of M2 muscarinic receptors in the rat brain identified by using a selective radioligand [3H]AF-DX 116

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Deficits in iodine-labelled 3-quinuclidinyl benzilate binding in relation to cerebral blood flow in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Correction of the stereochemical assignment of the benzilic acid center in (R)-(-)-3-quinuclidinyl (S)-(+)-4-iodobenzilate [(R,S)-4-IQNB]

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

The pedunculopontine nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2803%2900002-4

7 January 2021

10.1016/S0891-0618(03)00002-4

Identifiers

DOI

1 reference

2 December 2017

1 reference